Zobrazeno 1 - 10
of 279
pro vyhledávání: '"H.E. Kaufmann"'
Autor:
Youchao Dai, Chuanzhi Zhu, Wei Xiao, Kaisong Huang, Xin Wang, Chenyan Shi, Dachuan Lin, Huihua Zhang, Xiaoqian Liu, Bin Peng, Yi Gao, Cui Hua Liu, Baoxue Ge, Stefan H.E. Kaufmann, Carl G. Feng, Xinchun Chen, Yi Cai
Publikováno v:
The Journal of Clinical Investigation, Vol 133, Iss 8 (2023)
Ferritin, a key regulator of iron homeostasis in macrophages, has been reported to confer host defenses against Mycobacterium tuberculosis (Mtb) infection. Nuclear receptor coactivator 4 (NCOA4) was recently identified as a cargo receptor in ferritin
Externí odkaz:
https://doaj.org/article/3478bdbf22844e8aa84990870d3c58ed
Autor:
Walter A. Orenstein
Publikováno v:
New England Journal of Medicine. 354:651-652
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d23baeef53872a8ca65ea51c4cc01c4d
https://doi.org/10.1056/nejmbkrev39278
https://doi.org/10.1056/nejmbkrev39278
Autor:
Stephen J. Chanock
Publikováno v:
New England Journal of Medicine. 352:1933-1934
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3a5174e6f36c7896ace428f97ed5c8c5
https://doi.org/10.1056/nejm200505053521825
https://doi.org/10.1056/nejm200505053521825
Autor:
Stefan H.E. Kaufmann
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 15, Iss 11, Pp 2660-2665 (2019)
Infectious diseases remain a major health threat, not only in resource-poor countries but also in pockets of poverty within middle-income and sometimes high-income countries. Whilst strong research and development for novel vaccines are urgently need
Externí odkaz:
https://doaj.org/article/b81947e588b640438351ac4620da2398
Autor:
Anh Thu Dang, Juliane Strietz, Alessandro Zenobi, Hanif J. Khameneh, Simon M. Brandl, Laura Lozza, Gregor Conradt, Stefan H.E. Kaufmann, Walter Reith, Ivo Kwee, Susana Minguet, Sonia T. Chelbi, Greta Guarda
Publikováno v:
iScience, Vol 24, Iss 1, Pp 101900- (2021)
Summary: BTN3A molecules—BTN3A1 in particular—emerged as important mediators of Vγ9Vδ2 T cell activation by phosphoantigens. These metabolites can originate from infections, e.g. with Mycobacterium tuberculosis, or by alterations in cellular me
Externí odkaz:
https://doaj.org/article/de729f8b994f4debb0363e2537507785
Autor:
Alberto Eugenio Tozzi
Publikováno v:
New England Journal of Medicine. 351:2025-2025
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1849e041c43654cd7843c1c9eeb193b4
https://doi.org/10.1056/nejm200411043511927
https://doi.org/10.1056/nejm200411043511927
Autor:
Len W Poulter
Publikováno v:
Immunology Today. 20:385
Academic Press, 1998. $59.95 (xiv+705 pages)ISBN 0 12 402305 3This volume represents number 25 in the series Methods in Microbiology. It is a multiauthor book that includes contributions from a worldwide selection of experts in microbiology and immun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f6b56442855436a0680f7810cd889e5d
https://doi.org/10.1016/s0167-5699(99)01487-5
https://doi.org/10.1016/s0167-5699(99)01487-5
Publikováno v:
Expert Review of Vaccines, Vol 16, Iss 8, Pp 845-853 (2017)
Introduction: The most recent estimates on tuberculosis (TB) morbidity and mortality reveal that the global disease burden is even higher than previously assumed. Better drugs, diagnostics and vaccines are major requirements to control the ongoing TB
Externí odkaz:
https://doaj.org/article/d2f3470329424f499a0d6811ec55baff
Autor:
January Weiner, Stefan H.E. Kaufmann
Publikováno v:
International Journal of Infectious Diseases, Vol 56, Iss C, Pp 258-262 (2017)
High-throughput techniques strive to identify new biomarkers that will be useful for the diagnosis, treatment, and prevention of tuberculosis (TB). However, their analysis and interpretation pose considerable challenges. Recent developments in the hi
Externí odkaz:
https://doaj.org/article/1f6a7f460665465297feede5cd454fd9
Publikováno v:
International Journal of Infectious Diseases, Vol 56, Iss C, Pp 263-267 (2017)
Tuberculosis (TB) remains the deadliest infectious disease. The widely used bacille Calmette–Guérin (BCG) vaccine offers only limited protection against TB. New vaccine candidates for TB include subunit vaccines and inactivated whole-cell vaccines
Externí odkaz:
https://doaj.org/article/c451dcd1b39944de862062acf01e2428